NovoCure LimitedNVCRNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+13.3%
5Y CAGR+9.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+13.3%/yr
vs +9.4%/yr prior
5Y CAGR
+9.4%/yr
Recent acceleration
Acceleration
+3.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $166.88M | +21.6% |
| 2024 | $137.18M | +6.9% |
| 2023 | $128.28M | +11.7% |
| 2022 | $114.87M | -0.0% |
| 2021 | $114.88M | +7.9% |
| 2020 | $106.50M | +20.2% |
| 2019 | $88.61M | +10.7% |
| 2018 | $80.05M | +43.9% |
| 2017 | $55.61M | +20.2% |
| 2016 | $46.28M | - |